Imagine you have a minor cut and the bleeding does not stop. This can happen to those people with Hemophilia. It is an inherited bleeding disorder where the body lacks the ability to make blood clots, a process needed to stop bleeding. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. Small cuts usually aren’t much of a problem. In severe conditions, bleeding that happens inside the body especially knees, ankles, elbows and brain can damage your organs and tissues and can be life-threatening.

There are several different types of hemophilia. Hemophilia A (Classic Hemophilia) caused by a lack or decrease of clotting factor VIII and Hemophilia B (Christmas Disease) caused by a lack or decrease of clotting factor IX are the two most common types. Hemophilia A is the most common X-linked genetic disease with a worldwide incidence of approximately 1 case per 5000 males, with approximately one-third of affected individuals not having a family history of the disorder. Hemophilia B occurs in approximately 1 in 25,000 male births. It is less prevalent than hemophilia A.

The condition is not curable currently, but it can be treated to minimize symptoms and prevent future health complications. Genetic counselling is the main tool for the prevention and control of genetic disorders, targeted at families with an affected birth or with a family history of the disorder.

What causes this disorder and who are at the risk?

Hemophilia occurs when a clotting factor is missing or levels of the clotting factor are low. The majority of hemophilia cases are congenital which means that a person is born with the condition. One can also develop acquired hemophilia with no personal or family history of hemophilia. However, acquired hemophilia is a rare autoimmune disorder.

The biggest risk factor for developing this disorder is having family members who also have the disorder. Haemophilia predominantly affects the males.

Signs and Symptoms to watch out for

Depending on the level of clotting factors, signs and symptoms of hemophilia vary. In mild conditions, the bleeding is moderate and might bleed only after surgery or trauma. However, in severe cases, one can bleed easily for seemingly no reason. Some of the common signs and symptoms include:

1. Bleeding into the joints

2. Bleeding into the skin (which is bruising) or muscle and soft tissue causing a build-up of blood in the area (called a hematoma)

3. Bleeding of the mouth and gums, and bleeding that is hard to stop after losing a tooth

4. Bleeding unusually after vaccinations

5. Bleeding in the head of an infant after a difficult delivery.

6. Blood in the urine or stool

7. Nosebleeds without a known cause

8. Delayed bleeding after an injury

Although very rare, sometimes a simple bump on the head can cause bleeding into the brain for some people who have severe hemophilia. It is a state of emergency and immediate medical help must be taken.  Severe headache, vomiting repeatedly, seizures, feeling lethargy or seeing double vision or sudden excessively sleepiness are some of the signs.

Diagnosis:

It is usually diagnosed through a blood test. It helps identify the type of hemophilia and its severity. Reviewing the symptoms, personal medical history and clinical evaluation are recommended.  Since the disorder affects males in general, many people with a family history of hemophilia get their baby boys tested soon after birth.

Treatment:

Treatment focuses on replacing the missing protein and preventing complications. It involves giving or replacing the clotting factors that are too low or missing. This is done by infusing (administering through a vein) commercially prepared concentrated FVIII or FIX product.

In more severe cases, one may need to go to physical therapy for rehabilitation if hemophilia has damaged your joints. And, if you have pain associated with the condition, your doctor may prescribe or recommend pain medications to help alleviate the pain.

Also Read: World Hemophilia Day: Lets pledge to raise awareness 

Dr. Stallin Ramprakash

Consultant – Paediatric Haematology, Oncology & BMT

The post Hemophilia : Causes, risk and treatment appeared first on Health Vision.

New Delhi, INDIA, April 20, 2020: On World Hemophilia Day (April 17), Takeda India, part of Takeda Pharmaceutical Company Limited, a global biopharmaceutical company,pledged to stand united to support patients for a better life and brighter future.Takeda is committed to driving awareness and conversations around Hemophilia to ensure an increased number of diagnoses and, thus, timely treatment with quality replacement therapy.

Koki Sato, General Manager, Takeda India, commented, “As a company, we are committed to serving patients suffering from Hemophilia and support them in their journey to ensure an improved quality of life. Together with the hematology community, we are raising expectations for the future, including earlier diagnosis, earlier and full protection against bleeds, and more personalized patient care. With our innovative therapies, awareness drives, and initiatives, we aim to contribute towards building a bleed free India by 2030.”

Through Access to Medicine (AtM) strategy, Takeda aims to address the broader structural barriers that prevent patients in underserved communities from receiving the care and treatment they deserve. In addition to AtM, Takeda India in 2017, launched PurnaSamparq, a patient support program to address the critical unmet needs of Hemophilic patients by offering them Counselling, Diagnostic, Physiotherapy, Nursing and Education Support under the guidance of the Consulting Physician to improve the quality of life.

Gopal Agrawal, Head Market Access, Patient Advocacy, and Patient Services, Takeda India, said “We are committed to addressing the unmet needs of patients wherever they may be, and sustainably strengthening local health systems at every stage of the patient journey. We complement this approach with a commitment towards developing an end-to-end access approach to make our highly-innovative medicines available as soon as practically possible”.

Hemophilia is an inherited single gene disorder that is usually inherited, and about one in every 5,000 males is born with the disorder[2]. As per a reputed patient body in the country, there are approximately 21,000 registered hemophilia patients in India (footnote source). This rare disease mostly impacts pediatric males. While most of the patients opt for on-demand treatment when an episode of bleed occurs, there is prophylaxis treatment that can reduce the annual bleed rate, therefore leading to a reduced lifetime risk of future bleeds and helping the patients to live a better-quality life.

[1] http://www1.wfh.org/publications/files/pdf-1731.pdf.

[2] https://www.hemophilia.in/index.php/hemophilia/about-hemophilia

For more information: https://www.takeda.com

The post Takeda India stands united for Hemophilia appeared first on Health Vision.